On December 5, Senators Warren and Grassley sent a letter to the Acting FDA Commissioner, Brett Giroir, MD, pointing out the fact that the FDA previously announced that over-the-counter (OTC) hearing aid rules would be a priority on their fall 2018 Unified Agenda and they would likely deliver the proposed rules well in advance of the August 2020 statutory deadline. Senators Warren and Grassley note that “it is now December 2019 and we have yet to see these regulations come to fruition.”
Citing the serious nature of hearing difficulties and the related conditions that frequently accompany them, the letter requests that the FDA provide an update on the status of the OTC hearing aid rules and regulations and when the FDA expects to finalize the OTC hearing aid rules no later than December 19, 2019.
Recent Posts
Q4 SPAN Meeting to Focus on the ASLP-IC Compact
The American Academy of Audiology’s State Policy Advocate Network (SPAN) will hold its fourth-quarter meeting on October 28, 2026, from 8:00–9:00 pm ET. The meeting…
Tympanostomy Tubes Found in the Middle Ear Space: A Case Report
The placement of pressure equalization (PE) tubes is common procedure and often used for management of otitis media with effusion (OME), recurrent acute otitis media…
Cochlear Implant Satisfaction
Approximately 118,000 adults and 65,000 children in the United States have cochlear implants (CI) (National Institutes of Health, 2021). Most CIs require an external processor,…
